Answers are grounded in this paper and cite their sources.
Abstract This study investigates the synthesis of vinblastine by endophytic fungi Alternaria alternata (CRL 17), Curvularia lunata (CRL 28), Aspergillus terrus (CRL 52), and Aspergillus clavatonanicus (CRL 22), isolated from the leaf of Catharanthus roseus. The initial screening for secretion of plant alkaloids (vinca alkaloids) by fungi was performed by utilizing biochemical tests and thin-layer chromatography (TLC) which resulted total of 10 potential endophytes. Out of these ten, only four fungal extracts showed positive results for presence of vinblastine at same retention time (10 min.) compared to reference compound on HPLC analysis. The detected concentration of vinblastine was maximum (17 µg/ml) in Aspergillus clavatonanicus (CRL 22). The presence of vinblastine was further validated through ultra-high-performance liquid chromatography coupled with high-resolution accurate mass spectrometry (HRMS) analysis. The identification of anhydrovinblastine was validated through mass spectrometry, where molecular ions were observed at m/z 793.4185. The intermediate compounds which are involved in biosynthetic pathway of vinblastine were also identified in extract of Alternaria alternata (CRL 17). The study demonstrates that not only vinblastine but several other compounds of host origin have also been identified supporting the presence of biosynthetic pathway in endophytic fungus.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: